Contrast Media Market

Contrast Media Market (Type: Iodine-based Compounds, Barium Sulfate-bsed Compounds, Gadolinium-based Compounds, and Microbubbles/Microspheres; Application: Oncology, Cardiology, Neurology, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Market Outlook 2031

  • The global contrast media market size stood at US$ 4.9 Bn in 2022
  • It is expected to increase at a CAGR of 5.2% from 2023 to 2031 and reach US$ 7.8 Bn by the end of 2031

Analysts’ Viewpoint

Rise in number of cancer cases is driving the demand for image-guided, minimally invasive surgical operations, which in turn is expected to propel the contrast media market growth during the forecast period. Furthermore, increase in demand for advanced and more accurate imaging procedures is likely to prompt leading players to launch new products and acquire approval for novel indications.

Key manufacturers of contrast enhancers and imaging contrast agents should increase investment in R&D activities for stronger imaging, and better patient diagnoses, treatment, and health. Moreover, rise in number of approvals for contrast agents and advancements in diagnostic modalities are estimated to offer lucrative contrast media market opportunities to manufacturers across the globe.

Contrast Media Market

Market Introduction

Imaging contrast agents are chemicals used in medical imaging procedures, such as X-rays, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, to improve the visibility of internal organs or structures in the human body. These agents or medications are taken orally or injected into the body.

Increase in aging population and incidence of chronic diseases is fueling the demand for accurate interventional diagnostics. Radiology, interventional radiology, and interventional cardiology depend on radiographic contrast agents to identify health disorders and determine treatment for patients. Moreover, contrast media is increasingly being utilized to detect cancer, gastrointestinal disorders, and neurological disorders.

Iodine-based contrast chemicals enhance the clarity of X-ray images and CAT scans. They improve visualization of the digestive tract, central nervous system, and various other interior organs. Furthermore, applications of ultrasonography have exceeded gynecology and obstetrics to include diagnosis of cancer, kidney stones, and the other clinical disorders. Thus, rise in demand for less intrusive instruments is boosting the demand for high-quality surgical imaging. This is a key factor driving the market revenue.

Contrast agents are generally considered safe in various diagnostic procedures; however, certain MRI contrast media side-effects and reactions associated with prolonged usage may hamper the contrast media market outlook in the near future. Furthermore, stringent regulations on the usage of these agents is also anticipated to restrain the contrast media industry progress during the forecast period.

Increase in Prevalence for Cancer to Boost Contrast Media Market Demand

According to the WHO, cancer is among the leading causes of fatalities across the globe. In 2020, around 10 million deaths were caused due to cancer alone. Contrast media provides a clear contrast between tissues, organs, and blood vessels, which helps physicians identify tumors or other abnormalities, and consequently, determine the course of treatment and patient care.

Therefore, rise in number of cases of cancer is driving the need for safe and effective diagnostic procedures such as CT scans, MRIs, and ultrasound, which in turn is estimated to propel the contrast media market size in the near future.

Rise in Demand for Early Diagnosis of Cancer to Propel Contrast Media Market Revenue

As per the American Cancer Society, among women in the U.S. in 2023, an estimated 297,790 cases of invasive breast cancer would be diagnosed, and 43,170 deaths are likely to occur. Early detection by mammography screening and improvements in imaging technology have contributed to declines in breast cancer death rates.

Among men and women in the U.S., an estimated 238,340 new cases of lung and bronchus cancer would be diagnosed in 2023. Lung cancer is the leading cause of cancer death for both men and women; about 127,070 deaths are expected to occur in 2023. Furthermore, the Society suggests lowering the recommended age to begin annual screening with a low-dose computed tomography (LDCT) scan to age 50 years.

According to the CDC, cancer screening can detect cancer at early stages before symptoms occur, and it can be more successfully treated. Screening is considered a major factor that can prevent thousands of cancer deaths. Modern mammography programs can reduce breast cancer mortality by more than 40%. Therefore, rise in screening rate for early detection of cancer is anticipated to boost the market in the near future.

Regional Contrast Media Market Forecast

North America accounted for the largest contrast media market share in 2022, with key players focusing on enhancement of healthcare facilities, thereby catering to higher demand for diagnostic procedures. In the U.S., syringeless injectors are witnessing high demand, as they help in delivery of precise dose of the contrast agents.

As per the National Center for Biotechnology Information, neurological disorders represent over 13.3% of total disability-adjusted life years (DALYs) and 19.5% of fatalities in the EU. This factor is expected to accelerate the demand for contrast media in Europe (as a measure of early diagnosis) during the forecast period.

According to the region-wise market analysis, the business in Asia Pacific is expected to grow at a rapid pace with leading players establishing subsidiaries in countries such as India and China. For instance, GE Pharmaceuticals (Shanghai) Co., Ltd. is one of the branches of GE in China for diagnostic drugs (CT/MR contrast agents).

Analysis of Key Players

The global contrast media industry is highly consolidated with few prominent companies accounting for majority market share. Leading players are following the latest contrast media market trends and focusing on regulatory approvals, expansion through mergers & acquisitions, collaborations, and partnerships, in order to consolidate their presence in the global market. A few prominent entities operating in the global market include GE Healthcare, Bayer AG, Bracco Diagnostic, Inc., Guerbet Group, Lantheus Medical Imaging, Inc., nanoPET Pharma GmbH, Subhra Pharma Pvt. Ltd., and Spago Nanomedical AB.

Key Developments

  • In April 2023, GE Healthcare introduced Pixxoscan (gadubutrol) – a macrocyclic, gadolinium-based contrast agent (GBCA) for non-ionic MRI to be made available in the market in Europe
  • In October 2022, GE Healthcare’s pharmaceutical diagnostics company entered into a long-term agreement with Chile-based Sociedad Quimica y Minera (SQM) de Chile S.A. to ascertain supply of iodine used in X-Ray contrast media products
  • In July 2020, Bayer, in collaboration with Siemens Healthineers, launched a new-fangled Imaging System Interface (ISI) for MRI. The interface combines MR scanner from Siemens Healthineers and Bayer’s MR Injection System with the objective of overcoming challenges encountered by conventional methods.

Key players in the contrast media market report have been profiled based on various parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Global Contrast Media Market Snapshot

Attribute Detail
Market Value in 2022 (Base Year) US$ 4.9 Bn
Market Forecast Value in 2031 US$ 7.8 Bn
Growth Rate (CAGR) 5.2%
Forecast Period 2023-2031
Quantitative Units US$ Bn for Value
Market Analysis Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players – Competition Dashboard and Revenue Share Analysis, 2022
  • Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Market Segmentation
  • Type
    • Iodine-based Compounds
    • Barium Sulfate-based Compounds
    • Gadolinium-based Compounds
    • Microbubbles/Microspheres
  • Administration
    • Oral
    • Rectal
    • Intravenous/Intrarterial
    • Others
  • Imaging Modality
    • CT/X-Ray
    • Ultrasound
    • MRI
    • Others
  • Application
    • Oncology
    • Cardiology
    • Neurology
    • Others
Companies Profiled
  • GE Healthcare
  • Bayer AG
  • Bracco Diagnostic, Inc.
  • Guerbet Group
  • Lantheus Medical Imaging, Inc.
  • nanoPET Pharma GmbH
  • Subhra Pharma Pvt. Ltd.
  • Spago Nanomedical AB
Scope for Customization Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the contrast media market in 2022?

The global media was valued at US$ 4.9 Bn in 2022

How is contrast media industry expected to grow during the forecast period?

It is projected to grow at a CAGR of 5.2% from 2023 to 2031

What are the key factors driving the demand for contrast media?

Rise in prevalence of cancer and increase in demand for early diagnosis of cancer

Which contrast media segment held largest share in 2022?

In terms of application, the oncology segment held largest share in 2022

Which region is expected to dominate the contrast media business?

North America is estimated to dominate the global business in the next few years

Who are the key contrast media manufacturers?

GE Healthcare, Bayer AG, Bracco Diagnostic, Inc., Guerbet Group, Lantheus Medical Imaging, Inc., nanoPET Pharma GmbH, Subhra Pharma Pvt. Ltd., and Spago Nanomedical AB

    1. Executive Summary

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Contrast Media Market

    4. Market Overview

        4.1. Market Segmentation

            4.1.1. Segment Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Contrast Media Market Analysis and Forecast, 2022-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. List of Types of Diagnostic Imaging Tests

        5.3. COVID-19 Pandemic Impact on Industry

    6. Contrast Media Market Analysis and Forecast, by Type

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Type, 2017–2031

            6.3.1. Iodine-based Compounds

            6.3.2. Barium Sulfate-based Compounds

            6.3.3. Gadolinium-based Compounds

            6.3.4. Microbubbles/Microspheres

        6.4. Market Attractiveness, by Type

    7. Contrast Media Market Analysis and Forecast, by Administration

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Administration, 2017–2031

            7.3.1. Oral

            7.3.2. Rectal

            7.3.3. Intravenous/Intrarterial

            7.3.4. Others

            7.3.5. 7.4 Market Attractiveness, by Administration

    8. Global Contrast Media Market Analysis and Forecast, by Imaging Modality

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Imaging Modality, 2017–2031

            8.3.1. CT/X-Ray

            8.3.2. Ultrasound

            8.3.3. MRI

            8.3.4. Others

        8.4. Market Attractiveness, by Imaging Modality

    9. Global Contrast Media Market Analysis and Forecast, by Application

        9.1. Introduction and Definitions

        9.2. Key Findings/Developments

        9.3. Market Value Forecast, by Application, 2017–2031

            9.3.1. Oncology

            9.3.2. Cardiology

            9.3.3. Neurology

            9.3.4. Others

        9.4. 9.4 Market Attractiveness, by Application

    10. Global Contrast Media Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region, 2017–2031

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness, by Region

    11. North America Contrast Media Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Type, 2017–2031

            11.2.1. Iodine-based Compounds

            11.2.2. Barium Sulfate-based Compounds

            11.2.3. Gadolinium-based Compounds

            11.2.4. Microbubbles/Microspheres

        11.3. Market Attractiveness, by Type

        11.4. Market Value Forecast, by Administration, 2017–2031

            11.4.1. Oral

            11.4.2. Rectal

            11.4.3. Intravenous/Intrarterial

            11.4.4. Others

        11.5. Market Attractiveness, by Administration

        11.6. Market Value Forecast, by Imaging Modality, 2017–2031

            11.6.1. CT/X-Ray

            11.6.2. Ultrasound

            11.6.3. MRI

            11.6.4. Others

        11.7. Market Attractiveness, by Imaging Modality

        11.8. Market Value Forecast, by Application, 2017–2031

            11.8.1. Oncology

            11.8.2. Cardiology

            11.8.3. Neurology

            11.8.4. Others

        11.9. Market Attractiveness, by Application

        11.10. Market Value Forecast, by Country, 2022–2031

            11.10.1. U.S.

            11.10.2. Canada

        11.11. Market Attractiveness Analysis

            11.11.1. By Type

            11.11.2. By Administration

            11.11.3. By Imaging Modality

            11.11.4. Application

            11.11.5. By Country

    12. Europe Contrast Media Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Type, 2017–2031

            12.2.1. Iodine-based Compounds

            12.2.2. Barium Sulfate-based Compounds

            12.2.3. Gadolinium-based Compounds

            12.2.4. Microbubbles/Microspheres

        12.3. Market Attractiveness, by Type

        12.4. Market Value Forecast, by Administration, 2017–2031

            12.4.1. Oral

            12.4.2. Rectal

            12.4.3. Intravenous/Intrarterial

            12.4.4. Others

        12.5. Market Attractiveness, by Administration

        12.6. Market Value Forecast, by Imaging Modality, 2017–2031

            12.6.1. CT/X-Ray

            12.6.2. Ultrasound

            12.6.3. MRI

            12.6.4. Others

        12.7. Market Attractiveness, by Imaging Modality

        12.8. Market Value Forecast, by Application, 2017–2031

            12.8.1. Oncology

            12.8.2. Cardiology

            12.8.3. Neurology

            12.8.4. Others

        12.9. Market Attractiveness, by Application

        12.10. Market Value Forecast, by Country/Sub-region, 2022–2031

            12.10.1. Germany

            12.10.2. U.K.

            12.10.3. France

            12.10.4. Italy

            12.10.5. Spain

            12.10.6. Rest of Europe

        12.11. Market Attractiveness Analysis

            12.11.1. By Type

            12.11.2. By Administration

            12.11.3. By Imaging Modality

            12.11.4. By Application

            12.11.5. By Country/Sub-region

    13. Asia Pacific Contrast Media Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Type, 2017–2031

            13.2.1. Iodine-based Compounds

            13.2.2. Barium Sulfate-based Compounds

            13.2.3. Gadolinium-based Compounds

            13.2.4. Microbubbles/Microspheres

        13.3. Market Attractiveness, by Type

        13.4. Market Value Forecast, by Administration, 2017–2031

            13.4.1. Oral

            13.4.2. Rectal

            13.4.3. Intravenous/Intrarterial

            13.4.4. Others

        13.5. Market Attractiveness, by Administration

        13.6. Market Value Forecast, by Imaging Modality, 2017–2031

            13.6.1. CT/X-Ray

            13.6.2. Ultrasound

            13.6.3. MRI

            13.6.4. Others

        13.7. Market Attractiveness, by Imaging Modality

        13.8. Market Value Forecast, by Application, 2017–2031

            13.8.1. Oncology

            13.8.2. Cardiology

            13.8.3. Neurology

            13.8.4. Others

        13.9. Market Attractiveness, by Application

        13.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.10.1. China

            13.10.2. Japan

            13.10.3. India

            13.10.4. Australia & New Zealand

            13.10.5. Rest of Asia Pacific

        13.11. Market Attractiveness Analysis

            13.11.1. By Type

            13.11.2. By Administration

            13.11.3. By Imaging Modality

            13.11.4. By Application

            13.11.5. By Country/Sub-region

    14. Latin America Contrast Media Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Type, 2017–2031

            14.2.1. Iodine-based Compounds

            14.2.2. Barium Sulfate-based Compounds

            14.2.3. Gadolinium-based Compounds

            14.2.4. Microbubbles/Microspheres

        14.3. Market Attractiveness, by Type

        14.4. Market Value Forecast, by Administration, 2017–2031

            14.4.1. Oral

            14.4.2. Rectal

            14.4.3. Intravenous/Intrarterial

            14.4.4. Others

        14.5. Market Attractiveness, by Administration

        14.6. Market Value Forecast, by Imaging Modality, 2017–2031

            14.6.1. CT/X-Ray

            14.6.2. Ultrasound

            14.6.3. MRI

            14.6.4. Others

        14.7. Market Attractiveness, by Imaging Modality

        14.8. Market Value Forecast, by Application, 2017–2031

            14.8.1. Oncology

            14.8.2. Cardiology

            14.8.3. Neurology

            14.8.4. Others

        14.9. Market Attractiveness, by Application

        14.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.10.1. Brazil

            14.10.2. Mexico

            14.10.3. Rest of Latin America

        14.11. Market Attractiveness Analysis

            14.11.1. By Type

            14.11.2. By Administration

            14.11.3. By Imaging Modality

            14.11.4. By Application

            14.11.5. By Country/Sub-region

    15. Middle East & Africa Contrast Media Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Type, 2017–2031

            15.2.1. Iodine-based Compounds

            15.2.2. Barium Sulfate-based Compounds

            15.2.3. Gadolinium-based Compounds

            15.2.4. Microbubbles/Microspheres

        15.3. Market Attractiveness, by Type

        15.4. Market Value Forecast, by Administration, 2017–2031

            15.4.1. Oral

            15.4.2. Rectal

            15.4.3. Intravenous/Intrarterial

            15.4.4. Others

        15.5. Market Attractiveness, by Administration

        15.6. Market Value Forecast, by Imaging Modality, 2017–2031

            15.6.1. CT/X-Ray

            15.6.2. Ultrasound

            15.6.3. MRI

            15.6.4. Others

        15.7. Market Attractiveness, by Imaging Modality

        15.8. Market Value Forecast, by Application, 2017–2031

            15.8.1. Oncology

            15.8.2. Cardiology

            15.8.3. Neurology

            15.8.4. Others

        15.9. Market Attractiveness, by Application

        15.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.10.1. GCC Countries

            15.10.2. South Africa

            15.10.3. Rest of Middle East & Africa

        15.11. Market Attractiveness Analysis

            15.11.1. By Type

            15.11.2. By Administration

            15.11.3. By Imaging Modality

            15.11.4. By Application

            15.11.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        16.2. Market Share Analysis, by Company (2022)

        16.3. Company Profiles

            16.3.1. GE Healthcare

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Type Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Bayer AG

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Type Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Bracco Diagnostic, Inc.

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Type Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. Guerbet Group

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Type Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Lantheus Medical Imaging, Inc.

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Type Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. nanoPET Pharma GmbH

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Type Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. Subhra Pharma Pvt. Ltd.

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Type Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Spago Nanomedical AB

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Type Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

    List of Tables

    Table 1: Global Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 2: Global Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031

    Table 3: Global Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031

    Table 4: Global Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 5: Global Contrast Media Market Value (US$ Mn) Forecast, by Country/Region, 2017–2031

    Table 6: North America Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 7: North America Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031

    Table 8: North America Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031

    Table 9: North America Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 10: Europe Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 11: Europe Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 12: Europe Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031

    Table 13: Europe Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031

    Table 14: Europe Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 15: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 16: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 17: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031

    Table 18: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031

    Table 19: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 21: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 22: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031

    Table 23: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031

    Table 24: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 25: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 26: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 27: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031

    Table 28: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031

    Table 29: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031

    List of Figures

    Figure 1: Global Contrast Media Market Value (US$ Mn) Forecast, 2017–2031

    Figure 2: Contrast Media Market Value Share, by Type, 2022

    Figure 3: Contrast Media Market Value Share, by Administration, 2022

    Figure 4: Contrast Media Market Value Share, by Imaging Modality, 2022

    Figure 5: Contrast Media Market Value Share, by Application, 2022

    Figure 6: Global Contrast Media Market Value Share Analysis, by Type 2022 and 2031

    Figure 7: Global Contrast Media Market Attractiveness Analysis, Type, 2023–2031

    Figure 8: Global Contrast Media Market Value Share Analysis, by Administration 2022 and 2031

    Figure 9: Global Contrast Media Market Attractiveness Analysis, Administration, 2023–2031

    Figure 10: Global Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031

    Figure 11: Global Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031

    Figure 12: Global Contrast Media Market Value Share Analysis, by Application 2022 and 2031

    Figure 13: Global Contrast Media Market Attractiveness Analysis, Application, 2023–2031

    Figure 14: Global Contrast Media Market Value Share Analysis, by Country, 2022 and 2031

    Figure 15: Global Contrast Media Market Attractiveness Analysis, by Country, 2023–2031

    Figure 16: North America Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 17: North America Contrast Media Market Value Share Analysis, by Type 2022 and 2031

    Figure 18: North America Contrast Media Market Attractiveness Analysis, Type, 2023–2031

    Figure 19: North America Contrast Media Market Value Share Analysis, by Administration 2022 and 2031

    Figure 20: North America Contrast Media Market Attractiveness Analysis, Administration, 2023–2031

    Figure 21: North America Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031

    Figure 22: North America Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031

    Figure 23: North America Contrast Media Market Value Share Analysis, by Application 2022 and 2031

    Figure 24: North America Contrast Media Market Attractiveness Analysis, Application, 2023–2031

    Figure 25: Europe Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 26: Europe Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 27: Europe Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 28: Europe Contrast Media Market Value Share Analysis, by Type 2022 and 2031

    Figure 29: Europe Contrast Media Market Attractiveness Analysis, Type, 2023–2031

    Figure 30: Europe Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031

    Figure 31: Europe Contrast Media Market Attractiveness Analysis, Administration, 2023–2031

    Figure 32: Europe Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031

    Figure 33: Europe Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031

    Figure 34: Europe Contrast Media Market Value Share Analysis, by Application, 2022 and 2031

    Figure 35: Europe Contrast Media Market Attractiveness Analysis, Application, 2023–2031

    Figure 36: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 37: Asia Pacific Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 38: Asia Pacific Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 39: Asia Pacific Contrast Media Market Value Share Analysis, by Type 2022 and 2031

    Figure 40: Asia Pacific Contrast Media Market Attractiveness Analysis, Type, 2023–2031

    Figure 41: Asia Pacific Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031

    Figure 42: Asia Pacific Contrast Media Market Attractiveness Analysis, Administration, 2023–2031

    Figure 43: Asia Pacific Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031

    Figure 44: Asia Pacific Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031

    Figure 45: Asia Pacific Contrast Media Market Value Share Analysis, by Application, 2022 and 2031

    Figure 46: Asia Pacific Contrast Media Market Attractiveness Analysis, Application, 2023–2031

    Figure 47: Latin America Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 48: Latin America Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 49: Latin America Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 50: Latin America Contrast Media Market Value Share Analysis, by Type 2022 and 2031

    Figure 51: Latin America Contrast Media Market Attractiveness Analysis, Type, 2023–2031

    Figure 52: Latin America Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031

    Figure 53: Latin America Contrast Media Market Attractiveness Analysis, Administration, 2023–2031

    Figure 54: Latin America Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031

    Figure 55: Latin America Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031

    Figure 56: Latin America Contrast Media Market Value Share Analysis, by Application, 2022 and 2031

    Figure 57: Latin America Contrast Media Market Attractiveness Analysis, Application, 2023–2031

    Figure 58: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 59: Middle East & Africa Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 60: Middle East & Africa Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 61: Middle East & Africa Contrast Media Market Value Share Analysis, by Type 2022 and 2031

    Figure 62: Middle East & Africa Contrast Media Market Attractiveness Analysis, Type, 2023–2031

    Figure 63: Middle East & Africa Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031

    Figure 64: Middle East & Africa Contrast Media Market Attractiveness Analysis, Administration, 2023–2031

    Figure 65: Middle East & Africa Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031

    Figure 66: Middle East & Africa Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031

    Figure 67: Middle East & Africa Contrast Media Market Value Share Analysis, by Application, 2022 and 2031

    Figure 68: Middle East & Africa Contrast Media Market Attractiveness Analysis, Application, 2023–2031

    Figure 69: Global Contrast Media Market Share Analysis, by Company, 2022

Copyright © Transparency Market Research, Inc. All Rights reserved